These results suggest that exclusively considering LIP as a competitive inhibitor of LAP maybe too simple and that we have to differentiate between LIP and LAP functions in tumour biology as Spike and Rosen describe in their recent review “C/EBPβ isoform-specific regulation is more complicated than we may think”24. This evidence concerns the gene CEBPB and neoplasm.